Surface Oncology’s SRF388 Shows Promising Anticancer Activity in Pretreated Patients
Surface Oncology (NASDAQ:SURF) has announced new data from the ongoing Phase 1 studies of SRF388 and SRF617. SRF388 data will be…
Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer
Surface Oncology (NASDAQ:SURF) has entered into a clinical trial collaboration with Roche Holdings AG (OTC:RHHBY) to evaluate former’s SRF388, anti-IL-27 antibody, in combination…
Surface Oncology Reports Collaboration With Roche To Evaluate Co.’s Investigational Anti-IL-27 Antibody In Combo With Roche’s Atezolizumab, Bevacizumab In Patients With Treatment-Naïve Hepatocellular Carcinoma
Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced a clinical trial collaboration with Roche
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.
BTIG Initiates Coverage On Surface Oncology with Buy Rating, Announces Price Target of $17
BTIG analyst Justin Zelin initiates coverage on Surface Oncology (NASDAQ:SURF) with a Buy rating and announces Price Target of $17.
Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know
Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and entertainment company as analysts pointed to benefits from the reopening of theme parks in 2021.
Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip
Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ) on Wednesday.
60 Biggest Movers From Friday
Gainers iMedia Brands, Inc. (NASDAQ:IMBI) shares surged 42.2% to close at $4.48 on Friday after the company reported…